Results 51 to 60 of about 10,805,889 (142)

Freedom from any second malignancy and radiotherapy-related second malignancy.

open access: yes, 2013
Freedom from any second malignancy (solid line) and freedom from radiotherapy-related second malignancy (dashed line) in patients with nodular lymphocyte-predominant Hodgkin’s lymphoma treated with radiotherapy.
Melissa Horoschak LeMieux (460248)   +5 more
core   +1 more source

Correlation between chemotherapy in hepatocellular carcinoma and the risk of second primary malignancies

open access: yesCancer Treatment and Research Communications
Background: Treatments for hepatocellular carcinoma (HCC) currently include surgery, chemotherapy, interventional therapy, and immunotherapy. Recent investigations suggest that chemotherapy for certain malignancies may be linked to a higher risk of ...
Xiongpei Huang   +2 more
doaj   +1 more source

Hepatocellular carcinoma associated other primaries: common types and prognosis

open access: yesEgyptian Liver Journal, 2023
Hepatocellular carcinoma (HCC) is the commonest malignancy in Egypt secondary to endemic hepatitis virus. Dual malignancy with HCC is infrequently reported.
Saleh S. Elbalka   +2 more
doaj   +1 more source

Standardized incidence Ratios for developing a second malignancy after First Primary Uveal Melanoma

open access: yes, 2020
Standardized incidence Ratios for developing a second malignancy after First Primary Uveal Melanoma: For age groups: younger than 50 years old, Supplementary table 1 patients 50-70 years old, Supplementary table 2 patients older than 70 years ...
Ahmed Alfaar
core   +1 more source

Primary Pulmonary Actinomycosis Mimicking Malignancy [PDF]

open access: yes, 2018
The diagnosis of primary pulmonary actinomycosis (PPA) is still an important challenge in clinical practice due to its clinical and radiographic similarity with other infections and malignant diseases.
Guven, Merve Ilcin   +5 more
core   +1 more source

Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study

open access: yesEndocrine Connections, 2018
Purpose: Advances in cancer treatment achieved during the past decades have resulted in increased survival of most pediatric and adult patients that suffered from different adrenal tumor types.
Wafaa M Rashed   +8 more
doaj   +1 more source

Implementation of a metastatic malignancy of unknown primary origin service led by a palliative physician [PDF]

open access: yes, 2018
Background: Cancer of unknown primary is the fourth most common cause of cancer death in the United Kingdom. National guidance in 2010 recommended the establishment of a dedicated unknown primary team to facilitate targeted investigation and symptom ...
Ahmed, W.   +21 more
core   +1 more source

Identifying Subsets of Cancer Patients with an Increased Risk of Developing Cutaneous Melanoma: A Surveillance, Epidemiology, and End Results–Based Analysis

open access: yesJID Innovations
Cancer survivors have an increased risk of developing second primary malignancies. We aimed to identify whether certain cancers lead to an increased risk of developing melanoma among cancer survivors.
Thomas Z. Rohan   +9 more
doaj   +1 more source

The risk and prognosis factors of second primary malignancies in hepatocellular carcinoma survivors

open access: yesDiscover Oncology
Background With the prolongation of life expectancy in hepatocellular carcinoma (HCC) patients attributed to the advancement of treatments, the morbidity of second primary malignancies (SPM) has attracted considerable academic attention.
Yi Fang, Bo Lao, Wenjia Fang
doaj   +1 more source

Autopsy analysis may contribute to establish actual incidence of second primary malignancies in myeloma

open access: yesRare Tumors, 2015
Second primary malignancies (SPMs) are issues for patients with multiple myeloma (MM). There may have been some limitations in prior studies, such as difficulties in a longer follow-up and absence of established screening methods.
Junichiro Takano   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy